WeVote

Bill

Bill

SB 1488

Relating to restricting research on potentially pandemic pathogens in this state; creating a civil penalty.

89th Legislature (2025) Introduced by Bob Hall and 1 co-sponsor

Texas bill bans pandemic pathogen research within state borders and imposes civil penalties on violating institutions or researchers.

Co-author authorized
0
WeVote Research Nonpartisan
Bill Summary · SB 1488

Legislative bill overview

SB 1488 would prohibit research on potentially pandemic pathogens within Texas and establish civil penalties for violations. The bill appears designed to restrict gain-of-function research and other studies involving pathogens that could pose public health risks, imposing financial consequences on institutions or individuals who conduct such work.

Why is this important

This bill directly addresses biosafety and biosecurity concerns by attempting to control high-risk research at the state level. It raises questions about regulatory authority, institutional research capabilities, and whether state-level restrictions might conflict with federal oversight of dual-use research of concern (DURC).

Potential points of contention

  • Definitional ambiguity: The bill's core term "potentially pandemic pathogens" lacks precision, creating uncertainty about which research activities are actually prohibited and exposing institutions to unpredictable liability
  • Federalism conflict: Federal agencies (NIH, CDC) already regulate pathogen research; state penalties could create conflicting requirements and undermine coordinated national biosafety standards
  • Research competitiveness: Restrictions may disadvantage Texas institutions competing for federal research funding and talent, potentially driving researchers and grant money to other states
  • Enforcement challenges: Determining civil penalty amounts and enforcement mechanisms without clear definitions of prohibited activity could lead to arbitrary application

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.